top of page
BET Protein Inhibition for Pulmonary Arterial Hypertension
This pilot study added apabetalone to people's PAH therapy twice daily for 16 weeks to see if a future clinical trial evaluating...
PHA Canada
Mar 14, 20221 min read
bottom of page